Fibrex Medical Research & Development Gmbh

Calculating rank

USPTO Granted Patents = 5

% Expired Patents = 80.0

EPO Patents = 1

Forward Citations = 15

Loading Chart...

3 inventors (with patents filed for the assignee):

Peter Petzelbauer (5 out of 11 patents)

Sonja Reingruber (2 out of 5 patents)

Rainer Henning (2 out of 5 patents)

5 patents: Sort by Forward Citations

1. 8088890 - Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition (2012-01-03),

2. 8067533 - Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition (2011-11-29),

3. 8067373 - Therapeutic fibrin-derived peptides and uses thereof (2011-11-29),

4. 7494973 - Therapeutic fibrin-derived peptides and uses thereof (2009-02-24),

5. 7271144 - Therapeutic fibrin-derived peptides and uses thereof (2007-09-18),

Company Overview

Fibrex Medical Research & Development Gmbh is a leading medical technology company specializing in the research and development of innovative medical devices. With a focus on improving patient outcomes and advancing medical technologies, Fibrex is dedicated to bringing cutting-edge solutions to the healthcare industry. With a team of experienced researchers and engineers, Fibrex is committed to pushing the boundaries of medical innovation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#112 in Vienna

#519 in Austria

Vienna, Austria

Fibrex Medical Research & Development Gmbh

Forward Citations = 15

3 inventors:

Peter Petzelbauer (5 out of 11 patents)

Sonja Reingruber (2 out of 5 patents)

Rainer Henning (2 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fibrex Medical Research & Development Gmbh. Retrieved from https://idiyas.com/company/fibrex-medical-research-and-development

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]